Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 (PD-1) antigen and induces an immune response against tumor tissues. It has been successful in inducing remission in patients with severe metastatic disease, often refractory to other chemotherapeutic ag...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Nephrol Dial
Main Authors: Hanna, Ramy M., Selamet, Umut, Bui, Patrick, Sun, Shih-Fan, Shenouda, Olivia, Nobakht, Niloofar, Barsoum, Marina, Arman, Farid, Rastogi, Anjay
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2018
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120420/
https://ncbi.nlm.nih.gov/pubmed/30197906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491631
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki